Navigation Links
Actavis Full Year 2012 Net Revenue Increases 29% to $5.91 Billion
Date:2/19/2013

$6.3 billion and $6.5 billion.
  • Total Actavis Specialty Brands segment revenue of between $550 million and $600 million.
  • Total Anda Distribution segment revenue of between $1.0 billion and $1.2 billion.
  • Adjusted non-GAAP earnings for 2013 is expected to be between $7.70 and $8.10 per diluted share.*
  • Adjusted EBITDA for 2013 is expected to be between $1.87 billion and $1.94 billion.*
  • *See Tables 6 and 7 and accompanying notes. 

    Webcast and Conference Call DetailsActavis will host a conference call and webcast today at 8:30 a.m. Eastern Standard Time to discuss fourth quarter and full year 2012 results, the outlook for 2013 and recent corporate developments.  The dial-in number to access the call is US/Canada (877) 251-7980, International (706) 643-1573.  The Conference ID is 94810189.

    A taped replay of the conference call will also be available beginning approximately two hours after the call's conclusion and will remain available through 12:00 midnight Eastern Time on March 5, 2013.  The replay may be accessed by dialing (855) 859-2056 and entering pass code 94810189.  From international locations, the replay may be accessed by dialing (404) 537-3406 and entering the same pass code.  To access the webcast, go to Actavis' Investor Relations Web site at http://ir.actavis.com.  A replay of the webcast will also be available.

    About Actavis, Inc.
    Actavis, Inc. (NYSE: ACT) is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products.  The Company has global and U.S. headquarters in Parsippany, New Jersey, USA, and international headquarters in Zug, Switzerland. 

    Actavis is the world's third-largest generics prescription drug manufacturer.&
    '/>"/>

    SOURCE Actavis, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

    Related medicine technology :

    1. Watson to Acquire Actavis Group for EUR4.25 Billion
    2. Actavis Launches First Generic Equivalent of Requip® XL (Ropinirole Extended-Release Tablets)
    3. Actavis Launches Generic Equivalent of Adalat® CC 90mg (Nifedipine Extended-Release Tablets, USP)
    4. Watson and Actavis Receive FTC Second Request
    5. Watson Announces New Name -- Actavis -- for Global Operations
    6. Watson Pharmaceuticals, Inc. is Now Actavis, Inc.
    7. Actavis, Inc. to Host Fourth Quarter 2012 Earnings Conference Call and Webcast
    8. Actavis, Inc. to Present at the RBC Capital Markets Healthcare Conference
    9. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
    10. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
    11. Aethlon Medical Note: Fiscal Year Revenue Guidance
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/30/2015)... Massachusetts y LONDRES, August 30, 2015 /PRNewswire/ ... ofrece una visión holística de l ... todo el trayecto   ... hoy el debut europeo de IntelliSpace Cardiovascular , ... que ofrece sofisticadas herramientas para acceder, analizar y compartir ...
    (Date:8/29/2015)... August 29, 2015 La ... para los sistemas de imagen por Ultrasonidos   ofrece ... de examen rápidos y un flujo de trabajo   ... en el proceso de detección de Cardiopatías   ... anunciado hoy el lanzamiento europeo de HeartModel A.I ...
    (Date:8/28/2015)... , Aug. 28, 2015  With the heroin ... reaching deadlier heights, Jacksonville -based Lakeview ... Hemphill is helping to explain why fentanyl is ... approximately 40 to 50 times more potent than pharmaceutical ... users as heroin, the risk of death skyrockets. ...
    Breaking Medicine Technology:Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 2Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 3Philips presenta HeartModel A.I en el Congreso ESC 2015 2Philips presenta HeartModel A.I en el Congreso ESC 2015 3Philips presenta HeartModel A.I en el Congreso ESC 2015 4Philips presenta HeartModel A.I en el Congreso ESC 2015 5Lakeview Health's Dr. Philip Hemphill Explains Why Heroin Addicts Are Now Dying of Fentanyl Overdoses 2
    ... N.J., Oct. 4 Medco Health Solutions, Inc. ... its third-quarter 2010 financial results in a press ... 2, 2010.   (Logo: http://photos.prnewswire.com/prnh/20100609/MEDCOLOGO) ... management will hold a conference call at 8:30 ...
    ... VIVUS, Inc. (Nasdaq: VVUS ) today ... agreement with Meda - an international specialty pharma company ... erectile dysfunction (ED).  Under the agreement, Meda will acquire ... MUSE patents, existing inventory and the manufacturing facility located ...
    Cached Medicine Technology:Medco Announces Date for Third-Quarter 2010 Financial Results 2VIVUS Announces Sale of MUSE Assets to Meda 2VIVUS Announces Sale of MUSE Assets to Meda 3
    (Date:8/30/2015)... (PRWEB) , ... August 31, 2015 , ... ... jobs and a third of tax receipts, issues that are critically important to ... have bands of attorneys and lobbyists monitoring proposed legislation and changing tax and ...
    (Date:8/30/2015)... ... August 31, 2015 , ... ... Cooking Magazine for Kids , recently elected two new officers to serve on ... further ChopChop’s mission of inspiring and teaching kids to cook real food with ...
    (Date:8/30/2015)... Auckland, NZ (PRWEB) , ... August 30, 2015 ... ... enterprise collaboration across platforms and devices, today announced it is a Silver Sponsor ... 1, 2015 at Sky City Convention Centre in Auckland, NZ. Throughout the event, ...
    (Date:8/30/2015)... ... 30, 2015 , ... InHealth Media ( http://www.inhealthmedia.com ) announced ... Director for InHealth Media. Mr. Spector comes with a wide array of ... on-air television, producing shows, on air-radio and media relations. , Brian joins ...
    (Date:8/30/2015)... ... 30, 2015 , ... Nutritional Products International ( http://www.nutricompany.com ) ... global cosmeceutical and skin care brands. Mr. Fernandez comes with a wide ... working in operations, purchasing and management for some of the nations biggest retail ...
    Breaking Medicine News(10 mins):Health News:Newport Board Group, an Advisory Firm Serving the Middle Market, Issues Five Tips on Selling Services to the Government 2Health News:Newport Board Group, an Advisory Firm Serving the Middle Market, Issues Five Tips on Selling Services to the Government 3Health News:Newport Board Group, an Advisory Firm Serving the Middle Market, Issues Five Tips on Selling Services to the Government 4Health News:ChopChop Kids Appoints New Chair and Vice-Chair to Board of Directors 2Health News:ChopChop Kids Appoints New Chair and Vice-Chair to Board of Directors 3Health News:AvePoint Showcases the Future of Enterprise Collaboration as Silver Sponsor of the Digital Workplace Conference in New Zealand 2Health News:AvePoint Showcases the Future of Enterprise Collaboration as Silver Sponsor of the Digital Workplace Conference in New Zealand 3Health News:AvePoint Showcases the Future of Enterprise Collaboration as Silver Sponsor of the Digital Workplace Conference in New Zealand 4Health News:InHealth Media Appoints New Global Communications Director 2Health News:NPI Executive Vice President Leads Cosmeceutical Expansion 2
    ... Dec. 4 Accuray Incorporated,(Nasdaq: ARAY ), a ... company has hired Derek Bertocci as its chief financial officer. ... been serving as the chief financial officer of BioForm,Medical, Inc., ... October 2006, will begin at Accuray on January 1,2009. , ...
    ... bring sports flavor to the conversation about a serious men,s health ... ... -- College basketball analyst and sports ambassador Dick Vitale and co-host ... ESPN, The V Foundation for Cancer Research® and Stand Up To ...
    ... Dec. 4 Decision Resources, one of the,world,s ... and,healthcare issues, finds that Eisai/Helsinn Healthcare,s Aloxi,s marketing,message ... the most influential,by oncologists in the chemotherapy-induced nausea ... with the brand,highlighting the strength of the Aloxi ...
    ... , VALENCIA, Calif., Dec. 4 ... has met the primary endpoints of its final two pivotal Phase 3 ... company expects to disclose more details of the top-line data from these ... and 102) by mid-December. , , ...
    ... about a serious men,s health threat , ... basketball analyst and sports ambassador Dick Vitale and co-host of ... with ESPN, The V Foundation for Cancer Research(R) and Stand ... discussion about the often ignored reality of prostate cancer and ...
    ... Inc.,(NYSE: NUS ) today announces its 2009 financial ... at 9 a.m. at the Grand Hyatt,Hotel in New York ... operational results and outline plans,for 2009. , ... and we look forward to rounding out 2008,on a positive ...
    Cached Medicine News:Health News:Accuray Hires Chief Financial Officer 2Health News:Accuray Hires Chief Financial Officer 3Health News:ESPN'S Dick Vitale and Michael Wilbon Stand Up in the Fight Against Prostate Cancer 2Health News:ESPN'S Dick Vitale and Michael Wilbon Stand Up in the Fight Against Prostate Cancer 3Health News:ESPN'S Dick Vitale and Michael Wilbon Stand Up in the Fight Against Prostate Cancer 4Health News:Oncologists Rank Aloxi's Marketing Message Most Influential in the Chemotherapy-Induced Nausea and Vomiting Drug Market 2Health News:MannKind Reports Positive Results from Final Two Pivotal Phase 3 Clinical Studies in Type 1 and Type 2 Diabetes 2Health News:MannKind Reports Positive Results from Final Two Pivotal Phase 3 Clinical Studies in Type 1 and Type 2 Diabetes 3Health News:ESPN's Dick Vitale and Michael Wilbon Stand Up in the Fight Against Prostate Cancer 2Health News:ESPN's Dick Vitale and Michael Wilbon Stand Up in the Fight Against Prostate Cancer 3Health News:ESPN's Dick Vitale and Michael Wilbon Stand Up in the Fight Against Prostate Cancer 4Health News:Nu Skin Enterprises Offers 2009 Guidance During Annual Investor Day 2Health News:Nu Skin Enterprises Offers 2009 Guidance During Annual Investor Day 3
    The adult underbody blanket is conveniently positioned on the table before the patient arrives to the procedure suite....
    The cardiac access blanket helps maintain normothermia and allows unrestricted access to the patient....
    The full access underbody blanket is positioned on the procedure table before the patient arrives to the room....
    The fabric is antistatic and non-linting and is both oil and water repellent.These superior blankets are an environmental friendly alternative to disposable blankets....
    Medicine Products: